Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
about
Update on biologic safety for patients with psoriasis during pregnancy.Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel diseaseA safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease.Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy.The role of immunological testing and intervention in reproductive medicine: A fertile collaboration?
P2860
Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
@en
type
label
Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
@en
prefLabel
Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
@en
P2093
P2860
P921
P1476
Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
@en
P2093
Gary R Lichtenstein
Hamna Asim
Nabeel Khan
P2860
P304
P356
10.1517/14740338.2014.973399
P407
P577
2014-12-01T00:00:00Z